Worried about the next recession? Consider these FTSE 100 defensives

Non-cyclical sales growth and rising profits should make these FTSE 100 (INDEXFTSE: UKX) stocks a must-consider for nervous investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Good economic news keeps on rolling in and equity indices keep hitting fresh highs, but investors with a long memory will know from painful experience that the next recession is never too far away. With that in mind, it’s well worth considering dependable defensive shares that could hold their value when the next downturn hits.

Non-cyclical and growing fast

One sector that can depend on relatively robust demand throughout the economic cycle is pharmaceuticals. And of UK-listed pharma giants, one of my favourite is Shire (LSE: SHP). This is because the group has pivoted over the past few years to become a global leader in treatments for rare diseases, an area that commands high prices and has little competition.

In the first half of this year, the shift towards these higher-priced treatments paid off, with the group reporting a 3% constant currency uptick in revenue to $3.8bn. There was also a whopping 108% increase in operating profits, to $0.8bn, as costs related to its blockbuster Baxalta acquisition died down.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

During the period, the business generated a significant $756m in free cash flow, which allowed management to reduce net debt by some $1.4bn during the period, to $17.6bn. For the time being, management will need to continuing prioritising de-leveraging rather than boosting meagre dividends. But over the longer term, there’s some income potential if management doesn’t prioritise more acquisitions.

Unfortunately for domestic investors attracted to Shire, the company is currently in the process of being acquired by Japanese pharma giant Takeda, for £49 per share. However, Shire’s current share price is significantly below this level, as many investors believe either Takeda’s nervous shareholders, or regulators, will nix the debt-fuelled deal.

With this in mind, I’m not buying shares of Shire right now. But if Takeda’s bid falls through, and Shire’s share price drops, it’s certainly one defensive stock that would high on my watch list.

Everyone loves a coke

But with Shire possibly off the table for domestic investors, I think another defensive share worth considering is Coca-Cola HBC (LSE: HBC). Coca-Cola HBC is the brand’s bottler serving 28 countries, stretching from Italy and Ireland in the west, to Russia in the east, and Nigeria in the south.

The group’s defensive characteristics are quite high as consumers tend to continue making small purchases, like a bottle of Coke, throughout the business cycle. Furthermore, with more than half of its sales coming from developing and emerging markets, such as Hungary, Ukraine and Bosnia, its fortunes are less tied to economic health in key developed markets, like Western Europe and North America, than many other FTSE 100 peers.

Over the longer-term, exposure to these markets is a big positive since they’re generally experiencing high levels of economic and population growth. In the first six months of the year, these attributes helped boost volumes sold by 4.6% year-on-year, with net revenue up 6.4% on a constant currency basis to €3.2bn. The group’s management has also implemented margin improvement measures that increased operating profits during the perod by a whopping 14.1%, to €0.3bn.

Rising sales and margins are also fueling increases to the dividend that currently yields 1.87% annually. While this yield is below the FTSE 100 average, I think the company’s defensive nature and rising profits could make it a solid, non-cyclical option for nervous investors at its current price of 21 times forward earnings.

5 stocks for trying to build wealth after 50

Inflation recently hit 40-year highs… the ‘cost of living crisis’ rumbles on… the prospect of a new Cold War with Russia and China looms large, while the global economy could be teetering on the brink of recession.

Whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times. Yet despite the stock market’s recent gains, we think many shares still trade at a discount to their true value.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. We believe these stocks could be a great fit for any well-diversified portfolio with the goal of building wealth in your 50’s.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has recommended Shire. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Prediction: 12 months from now, £5,000 invested in Tesla stock could be worth…

Tesla stock has endured a miserable year so far, falling by 29%. Muhammad Cheema takes a look at how it…

Read more »

Investing Articles

See what £10,000 invested in Tesla shares at their mid-December peak is worth today 

As the world absorbs the full scale of Donald Trump's tariffs, Tesla shares are reeling. Investors who bought the stock…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Dividend Shares

2 ‘safe’ LSE dividend stocks to consider as global markets sell off

As global markets experience high levels of volatility due to economic uncertainty, investors are piling into these ‘safe-haven’ dividend stocks.

Read more »

Investing Articles

US stock market rout: an unmissable opportunity for investors?

His tech-heavy portfolio has been smashed by Trump’s tariffs. However, Dr James Fox believes there could be some opportunities in…

Read more »

Investing Articles

After a 13% ‘Trump tariff’ fall, is the Barclays share price too cheap to miss?

Does the Barclays share price fall mean we should all panic and run screaming from the stock market? Nah, of…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

2 investment trusts to consider for a Stocks and Shares ISA

These two investment trusts have a different focus -- but our writer sees both as worth considering, one more for…

Read more »

Investing Articles

Deutsche Bank reiterates Buy rating on 9.6% yielding FTSE 250 stock that was “most shorted in UK”

Our writer investigates why a major broker remains optimistic about a FTSE 250 stock that was once the most shorted…

Read more »

Investing Articles

2 things to remember when stock markets are turbulent

US trade policy has rattled the stock markets in New York, London and elsewhere. Our writer outlines a couple of…

Read more »